Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00085839
Status:
COMPLETED
Last Update Posted:
2012-08-09
First Post:
2004-06-15
Brief Title:
Erlotinib vs Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer NSCLC and Eastern Cooperative Oncology Group ECOGPerformance Status PS 2
Sponsor:
OSI Pharmaceuticals
Organization:
Astellas Pharma Inc
Organization Data
Organization:
Astellas Pharma Inc
Class:
INDUSTRY
Study ID:
OSI-774-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
OSI Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None